---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-026572"
form_type: "8-K"
ticker: "DNLI"
cik: "0001714899"
company_name: "Denali Therapeutics Inc."
filed_at: "2022-10-18T23:59:59+00:00"
generated_at: "2026-06-23T03:00:38.210698+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Denali Therapeutics announces $250M public offering of common stock

## Summary
- Denali to sell $250M of common stock; underwriters have 30-day option for additional 15%.
- Goldman Sachs, J.P. Morgan, and Jefferies act as joint book-running managers for the offering.
- Preliminary cash, cash equivalents, and marketable securities estimated at $1.11B as of Sep 30, 2022.
- Company has no approved products and expects to continue incurring significant net losses.

## SEC filing metadata
- accession: 0001628280-22-026572
- form_type: 8-K
- ticker: DNLI
- cik: 0001714899
- company_name: Denali Therapeutics Inc.
- filed_at: 2022-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1714899/000162828022026572/0001628280-22-026572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1714899/000162828022026572/dnli-20221018.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-026572
- JSON: https://secwatch.observer/filing/0001628280-22-026572.json
- Plain text: https://secwatch.observer/filing/0001628280-22-026572.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.